<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="336372">
  <stage>Registered</stage>
  <submitdate>4/01/2011</submitdate>
  <approvaldate>17/01/2011</approvaldate>
  <actrnumber>ACTRN12611000056998</actrnumber>
  <trial_identification>
    <studytitle>Positional therapy for obstructive sleep apnea: an objective measurement of efficacy and patients usage at home.</studytitle>
    <scientifictitle>Positional therapy for obstructive sleep apnea: an objective measurement of efficacy and patients usage at home.</scientifictitle>
    <utrn>NA</utrn>
    <trialacronym>NA</trialacronym>
    <secondaryid>NA</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Positional sleep apnea. i.e. sleep apnea occuring mainly in supine position</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Sleep apnoea</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Patients with positional sleep apnea are equipped with the positional device preventing sleep in supine position. Patients are instructed to use the device every night during a 3 months period. An actigraphic device, (movement sensor recorder system, Actiwatch, CamNtech Ltd, Cambridge, UK), is inserted inside the positional device in order to assess compliance; i.e., detect when patients used it.</interventions>
    <comparator>The device tested is bought from "Amrein Orthpedie, Lausanne Switzerland". No control group for ethical reasons.</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Number of nights (during the 3 months observation period) and the number of hours per night the device is used (according to the movement sensor inserted inside the positional device)</outcome>
      <timepoint>3 months</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Efficacy of the device as measured by apnea hypopnea index (number of apnea + hypopnea per hour of sleep) at the end of the 3 months follow-up</outcome>
      <timepoint>3 months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Positional sleep apnoea
Intolerance to other treatments such as CPAP or mandibular advancement device</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>100</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Intolerance to the positional device during the test night</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment>Patients diagnosed with mild to severe positional OSA (defined as a &gt; 50% reduction in AHI and an AHI &lt;10/h during sleep in non-supine posture) during a home diagnostic night study (baseline, night 1) are identified in our sleep centre population</concealment>
    <sequence>NA</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Single group</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>15/07/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>12</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Switzerland</country>
      <state>NA</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Lausanne University</primarysponsorname>
    <primarysponsoraddress>Faculte de biologie et medecine
Rue du Bugnon
1011 Lausanne
Switzerland</primarysponsoraddress>
    <primarysponsorcountry>Switzerland</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Lausanne University</fundingname>
      <fundingaddress>Faculte de biologie et medecine
Rue du Bugnon
1011 Lausanne
Switzerland</fundingaddress>
      <fundingcountry>Switzerland</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Positional therapy that prevents patients from sleeping supine has been used for many years to manage positional obstructive sleep apnea (OSA). However, the actual usage and long term efficacy of this therapy have never been objectively assessed.The aims of this study are to: 1) measure objective nightly usage of this positional device at home and, 2) assess its efficacy after 3 months of treatment at home.</summary>
    <trialwebsite>N.A.</trialwebsite>
    <publication>N.A.</publication>
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>lausanne University ethics committee</ethicname>
      <ethicaddress>Faculte de biologie et medecine
Rue du Bugnon
1011 Lausanne
Switzerland</ethicaddress>
      <ethicapprovaldate>1/07/2009</ethicapprovaldate>
      <hrec>NA</hrec>
      <ethicsubmitdate>28/05/2009</ethicsubmitdate>
      <ethiccountry>Switzerland</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Raphael Heinzer MD, MPH</name>
      <address>Center for Investigation and Research in Sleep (CIRS)
Lausanne University Hospital (CHUV)
BH 06-204
1011 Lausanne
Switzerland</address>
      <phone>+41 21 314 67 54</phone>
      <fax>+41 21 314 67 52</fax>
      <email>raphael.heinzer@chuv.ch</email>
      <country>Switzerland</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Raphael Heinzer MD, MPH</name>
      <address>Center for Investigation and Research in Sleep (CIRS)
Lausanne University Hospital (CHUV)
BH 06-204
1011 Lausanne
Switzerland</address>
      <phone>+41 21 314 67 54</phone>
      <fax>+41 21 314 67 52</fax>
      <email>raphael.heinzer@chuv.ch</email>
      <country>Switzerland</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Raphael Heinzer MD, MPH</name>
      <address>Center for Investigation and Research in Sleep (CIRS)
Lausanne University Hospital (CHUV)
BH 06-204
1011 Lausanne
Switzerland</address>
      <phone>+41 21 314 67 54</phone>
      <fax>+41 21 314 67 52</fax>
      <email>raphael.heinzer@chuv.ch</email>
      <country>Switzerland</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>